IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma.

IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma. Clin Cancer Res. 2018 06 01; 24(11):2559-2573.

View in: PubMed

subject areas

Animals
Antineoplastic Agents, Immunological
Cell Line, Tumor
Combined Modality Therapy
Disease Models, Animal
Drug Synergism
Energy Metabolism
Enzyme Activation
Enzyme Inhibitors
Glioblastoma
Humans
Indoleamine-Pyrrole 2,3,-Dioxygenase
Male
Mice
Mice, Knockout
Neoplasm Metastasis
Neoplasm Staging
Programmed Cell Death 1 Receptor
Radiation, Ionizing
Survival Analysis
T-Lymphocytes
Xenograft Model Antitumor Assays

authors with profiles

Kristen Lauing
Derek A. Wainwright